Request Deal Involvement

RA Capital Management led a $175m Series B round in Capstan Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ten Bridge Communications

pr advisors

Ten Bridge Communications

or

Principals

LEAPS BY BAYER

bidder

LEAPS BY BAYER

NOVARTIS VENTURE FUND

bidder

NOVARTIS VENTURE FUND

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

CAPSTAN THERAPEUTICS

target

CAPSTAN THERAPEUTICS

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

JOHNSON & JOHNSON INNOVATION - JJDC INC

bidder

JOHNSON & JOHNSON INNOVATION - JJDC INC

SOFINNOVA INVESTMENTS

bidder

SOFINNOVA INVESTMENTS

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

PFIZER VENTURES

bidder

PFIZER VENTURES

POLARIS PARTNERS

bidder

POLARIS PARTNERS

MUBADALA CAPITAL

bidder

MUBADALA CAPITAL

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

BRISTOL MYERS SQUIBB COMPANY

bidder

BRISTOL MYERS SQUIBB COMPANY

VIDA VENTURES

bidder

VIDA VENTURES

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - RA Capital Management led a $175m Series B round in Capstan Therapeutics.